×
Entrez Id: 902
Gene Symbol: CCNH
CCNH
Malignant neoplasm of prostate
0.320
Biomarker
CTD_human
Identification of recurrent fusion genes across multiple cancer types.
30705370 2019
×
Entrez Id: 90355
Gene Symbol: MACIR
MACIR
Malignant neoplasm of prostate
0.310
Biomarker
CTD_human
Identification of recurrent fusion genes across multiple cancer types.
30705370 2019
×
Entrez Id: 23210
Gene Symbol: JMJD6
JMJD6
Malignant neoplasm of prostate
0.300
Biomarker
CTD_human
Ras-Induced miR-146a and 193a Target Jmjd6 to Regulate Melanoma Progression.
30619488 2018
×
Entrez Id: 80381
Gene Symbol: CD276
CD276
Malignant neoplasm of prostate
0.350
Biomarker
CTD_human
CD276 and the alternative checkpoint inhibition PVR/NECTIN2/CD226/TIGIT pathway emerged as relevant to PC checkpoint inhibition target development.30614027 2019
×
Entrez Id: 5817
Gene Symbol: PVR
PVR
Malignant neoplasm of prostate
0.320
Biomarker
CTD_human
CD276 and the alternative checkpoint inhibition PVR /NECTIN2/CD226/TIGIT pathway emerged as relevant to PC checkpoint inhibition target development.
30614027 2019
×
Entrez Id: 5819
Gene Symbol: NECTIN2
NECTIN2
Malignant neoplasm of prostate
0.310
Biomarker
CTD_human
CD276 and the alternative checkpoint inhibition PVR/NECTIN2 /CD226/TIGIT pathway emerged as relevant to PC checkpoint inhibition target development.
30614027 2019
×
Entrez Id: 240
Gene Symbol: ALOX5
ALOX5
Malignant neoplasm of prostate
0.350
Biomarker
CTD_human
Mitochondrial uncoupling reveals a novel therapeutic opportunity for p53-defective cancers.
30258081 2018
×
Entrez Id: 242
Gene Symbol: ALOX12B
ALOX12B
Malignant neoplasm of prostate
0.300
Biomarker
CTD_human
Mitochondrial uncoupling reveals a novel therapeutic opportunity for p53-defective cancers.
30258081 2018
×
Entrez Id: 55035
Gene Symbol: NOL8
NOL8
Malignant neoplasm of prostate
0.310
Biomarker
CTD_human
Taken together, this study demonstrated the oncogenic roles of NOL8 in prostate cancer and suggested that NOL8 might be an important therapeutic target for prostate cancer .
30125550 2018
×
Entrez Id: 3148
Gene Symbol: HMGB2
HMGB2
Malignant neoplasm of prostate
0.320
Biomarker
CTD_human
Early detection of prostate carcinogens by immunohistochemistry of HMGB2.
29877212 2018
×
Entrez Id: 406899
Gene Symbol: MIR106A
MIR106A
Malignant neoplasm of prostate
0.340
Biomarker
CTD_human
We performed bioinformatics analyses of The Cancer Genome Atlas (TCGA) dataset to evaluate the association between miR-106a and its putative target lipopolysaccharide-induced TNF-α factor (LITAF) in prostate cancer .
29845714 2018
×
Entrez Id: 9516
Gene Symbol: LITAF
LITAF
Malignant neoplasm of prostate
0.320
Biomarker
CTD_human
miRNA-106a and prostate cancer radioresistance: a novel role for LITAF in ATM regulation.
29845714 2018
×
Entrez Id: 7415
Gene Symbol: VCP
VCP
Malignant neoplasm of prostate
0.330
Biomarker
CTD_human
This study determines VCP may play an important role in progression to CRPC and it can be a favorable target with to develop new therapies to treat ADT resistant prostate cancer .
29693262 2018
×
Entrez Id: 2308
Gene Symbol: FOXO1
FOXO1
Malignant neoplasm of prostate
0.400
Biomarker
CTD_human
Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets.
29662167 2018
×
Entrez Id: 283131
Gene Symbol: NEAT1
NEAT1
Malignant neoplasm of prostate
0.360
Biomarker
CTD_human
Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets.
29662167 2018
×
Entrez Id: 5295
Gene Symbol: PIK3R1
PIK3R1
Malignant neoplasm of prostate
0.350
Biomarker
CTD_human
Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets.
29662167 2018
×
Entrez Id: 4214
Gene Symbol: MAP3K1
MAP3K1
Malignant neoplasm of prostate
0.330
Biomarker
CTD_human
Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets.
29662167 2018
×
Entrez Id: 79718
Gene Symbol: TBL1XR1
TBL1XR1
Malignant neoplasm of prostate
0.320
Biomarker
CTD_human
Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets.
29662167 2018
×
Entrez Id: 5144
Gene Symbol: PDE4D
PDE4D
Malignant neoplasm of prostate
0.320
Biomarker
CTD_human
Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets.
29662167 2018
×
Entrez Id: 5520
Gene Symbol: PPP2R2A
PPP2R2A
Malignant neoplasm of prostate
0.320
Biomarker
CTD_human
Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets.
29662167 2018
×
Entrez Id: 53353
Gene Symbol: LRP1B
LRP1B
Malignant neoplasm of prostate
0.310
Biomarker
CTD_human
Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets.
29662167 2018
×
Entrez Id: 6091
Gene Symbol: ROBO1
ROBO1
Malignant neoplasm of prostate
0.310
Biomarker
CTD_human
Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets.
29662167 2018
×
Entrez Id: 26054
Gene Symbol: SENP6
SENP6
Malignant neoplasm of prostate
0.310
Biomarker
CTD_human
Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets.
29662167 2018
×
Entrez Id: 10863
Gene Symbol: ADAM28
ADAM28
Malignant neoplasm of prostate
0.310
Biomarker
CTD_human
Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets.
29662167 2018
×
Entrez Id: 54897
Gene Symbol: CASZ1
CASZ1
Malignant neoplasm of prostate
0.310
Biomarker
CTD_human
Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets.
29662167 2018